June 1, 2016
The trade name of the drug was initially Brintellix when it was approved in September 2013 and FDA approved a name change to minimize patient confusion over similarly named medication in early May. 
May 31, 2016

Zinbryta is a once-daily self-administered injection indicated to treat relapsing forms of multiple sclerosis in patients who have had an inadequate response to two or more MS therapies. 

 
May 31, 2016

The new drug is indicated as a once-daily adjunctive treatment for Type 2 diabetes and works by increasing hormones that stimulate insulin production in the pancreas and that stimulate the liver to produce less glucose.

May 25, 2016

CVS Health’s efforts to dispense opioid overdose reversal drug naloxone without a prescription has already come to 23 states and the company has announced plans to expand to seven more over the course of the summer.

May 25, 2016

In addition to naming a COO and EVP strategy, Gilead announced that its EVP commercial operations will be leaving the company to pursue other opportunities. 

 
May 24, 2016

The quadrivalent vaccine covers two strains each of influenza A and influenza B and is derived from a cell culture — the same cell culture technology the company used in its first product Flucelvax.

May 24, 2016

The drug has been approved as a first-line treatment for adults with type 2 diabetes who aren’t being treated with either canagliflozin or metformin. 

May 20, 2016

Mirvaso was approved in 2013 as a first-in-class treatment for rosacea-related redness, and according to Galderma it can start working for some patients 30 minutes after application and last up to 12 hours

May 19, 2016

An ongoing clinical trial has found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with the drug.

May 16, 2016

The Food and Drug Administration on Friday approved a new indication for Eisai’s Lenvima (lenvatinib). 

May 16, 2016
The message said that for patients with sinusistis, bronchitis and uncomplicated urinary tract infections who have other treatment options, the possible side effects of fluoroquinolone antibiotics outweigh the benefits.  
May 16, 2016

Pfizer’s acquisition will see the addition of Anacor’s flagship asset, crisaborole, a potential treatment for eczema, added to Pfizer’s inflammation and immunology portfolio. 

May 13, 2016

In the 2015 State of the Union address, President Barack Obama announced the launch of the Precision Medicine Initiative — a bold new research effort that can be actuated by MD Labs' Rxight, a pharmacogenetic program. 

May 11, 2016

By combining EHR data, historical patterns of flu activity and a machine-learning algorithm to interpret the data, the researchers made accurate predictions of national and local influenza activity.

May 11, 2016

Cigna has announced a deal with the makers of cholesterol drugs Amgen and Repatha to tie the drugs' price to the outcomes they provide.

May 9, 2016

A record number of Americans showed up last weekend to turn in their unused prescription drugs, according to the Drug Enforcement Agency. 

May 3, 2016

The news comes as the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) seeks to reduce the number of antibiotic prescriptions by 15% by 2020.

May 3, 2016

Kenneth Parks will join the company on June 6 and will oversee all of Mylan’s global finance functions, including accounting and control, financial planning and analysis, investor relations, treasury and tax. 

 
May 3, 2016

University of Utah School of Medicine researchers reported that infants 6 months and younger whose mothers were vaccinated when pregnant had a 70% reduction in laboratory-confirmed flu cases. 

May 3, 2016

Due partly to its small patient population, Taro said Keveyis has seen less than $1 million in sales since its launch, making the investment in marketing the drug unsustainable.

May 2, 2016

According to Veterans Affairs estimates, the price range for IUD costs to the military is $350 to $650 per device. Allergan will offer its IUD to the military treatment facilities and VA hospitals for $55.83.

May 2, 2016

Nuplazid (pimavanserin), from Acadia Pharmaceuticals, is the first medication to be approved to treat Parkinson’s-related psychosis, which affects some 40% of the 4-6 million patients with Parkinson’s disease.

May 2, 2016

The new oral formulation is interchangeable with the company’s Fycompa tablets, and Eisai expects to make it available in June.

April 29, 2016

The states with the highest rates of influenza, according to the Index, were Arizona, Texas, Kentucky, Mississippi and Tennessee.